高血压与心房颤动:AF-SCREEN国际协作的前沿综述
本前沿综述由AF-SCREEN国际协作的29位专家撰写,总结高血压与房颤关联、同步筛查及降压治疗预防房颤的现有证据与知识缺口。高血压是可调控的房颤首要危险因素,估计超过70%的房颤患者合并高血压。两者协同增加缺血性卒中、心衰和痴呆风险,但同步筛查和降压预防的最佳策略尚待明确。
要点
- 高血压是房颤首要可调控危险因素,超过70%房颤患者合并高血压。
- 具备技术的自动上臂袖带血压设备可同步检测高血压和房颤,但房颤阳性仍需心电图确认。
- ≥65岁或难治性高血压高危个体可能从房颤筛查中获益。
核心结论
- 高血压与房颤紧密关联,应作为房颤预测和预防的关键靶点而非仅视为合并症。
- 降压治疗可有效降低房颤风险,尤其在左心室功能障碍者中。
研究设计与样本
- AF-SCREEN国际协作29位专家撰写的前沿综述,总结现有证据和知识缺口。
主要发现
- 高血压估计存在于超过70%的房颤患者中。
- 高血压与房颤协同增加缺血性卒中、心力衰竭和多种类型痴呆的风险,导致全因死亡率升高。
- 具备技术的自动上臂袖带血压设备可同步检测高血压和房颤,但房颤阳性仍需心电图确认。
- 当前证据提示≥65岁或难治性高血压的高危个体可能从房颤筛查中获益。
- 降压治疗有效降低房颤风险,尤其在左心室功能障碍个体中。
关键数值与推荐
- 高危个体定义为年龄≥65岁或患有难治性高血压,可能从房颤筛查中获益。
- 房颤筛查阳性(通过示波法血压监测)仍需心电图确认。
临床怎么用
- 临床应重视高血压作为房颤预测和预防的关键靶点,而不仅视为合并症。
- 对≥65岁或难治性高血压患者可考虑房颤筛查,阳性者需心电图确认。
- 降压治疗应作为预防房颤的重要策略,尤其对左心室功能障碍者。
局限性
- 同步筛查高血压和房颤的理想方法和患者选择尚不明确。
- 预防房颤的最佳降压药物类别和血压目标尚待确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypertension is the leading modifiable risk factor for atrial fibrillation (AF) and is estimated to be present in >70% of AF patients. This Frontiers Review was prepared by 29 expert members of the AF-SCREEN International Collaboration to summarize existing evidence and knowledge gaps on links between hypertension, AF, and their cardiovascular sequelae; simultaneous screening for hypertension and AF; and the prevention of AF through antihypertensive therapy. Hypertension and AF are inextricably connected. Both are easily diagnosed, often silent, and frequently treated inadequately. Together, they additively increase the risk of ischemic stroke, heart failure, and many types of dementia, resulting in greater all-cause mortality, considerable disease burden, and increased health care expenditures. Automated upper arm cuff blood pressure devices with implemented technology can be used to simultaneously detect both hypertension and AF. However, positive screening for AF with an oscillometric blood pressure monitor still requires ECG confirmation. The current evidence suggests that high-risk individuals aged ≥65 years or with treatment-resistant hypertension could benefit from AF screening. Since antihypertensive therapy effectively lowers AF risk, particularly in individuals with left ventricular dysfunction, hypertension should be the key target for AF prediction and prevention rather than merely a comorbidity of AF. Nevertheless, several important gaps in knowledge need to be filled over the next years, including the ideal method and selection of patients for simultaneous screening of hypertension and AF and the optimal antihypertensive drug class and blood pressure targets for AF prevention.
引用
- Niiranen, Schnabel, Schutte, et al. Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration. Circulation. 2025. PMID: 40127157. doi:10.1161/CIRCULATIONAHA.124.071047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。